Journal article
Abstract GS1-01: Race and clinical outcomes in the RxPONDER Trial (SWOG S1007)
Abstract
Abstract
Introduction: Racial disparities in breast cancer (BC) outcomes continues to be a major health care challenge. The 21-gene recurrence score (RS) is an important tool to guide treatment (tx) decisions among women with early-stage BC. We report an analysis of clinical characteristics, survival outcomes and race in association with RS in participants (pts) in the RxPONDER trial.
Authors
Abdou Y; Barlow WE; Gralow JR; Meric-Bernstam F; Albain KS; Hayes DF; Lin NU; Perez EA; Goldstein LJ; Chia SK
Journal
Cancer Research, Vol. 83, No. 5_Supplement,
Publisher
American Association for Cancer Research (AACR)
Publication Date
March 1, 2023
DOI
10.1158/1538-7445.sabcs22-gs1-01
ISSN
0008-5472